{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:05Z","timestamp":1790484125927,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1084","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Approximately 10% of infective endocarditis (IE) involves the right side of the heart with the majority of these cases occurring in intravenous drug users. Patients are less likely to present with classical IE signs of a new murmur and peripheral stigmata, are more frequently immunocompromised and often have significant social difficulties. These factors result in both diagnostic and therapeutic challenges in this patient group that are not often seen in other patient populations with IE.<\/jats:p>","DOI":"10.1136\/postgradmedj-2015-133648","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T03:18:37Z","timestamp":1451531917000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":38,"title":["Infective endocarditis in intravenous drug users: a review article"],"prefix":"10.1093","volume":"92","author":[{"given":"Thomas","family":"Colville","sequence":"first","affiliation":[{"name":"Cardiology Department, Royal Liverpool University Hospital , Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[{"name":"Cardiology Department, Royal Liverpool University Hospital , Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Albouaini","sequence":"additional","affiliation":[{"name":"Cardiology Department, Royal Liverpool University Hospital , Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"2024020821224747000_bib1","volume-title":"Braunwald's heart disease: a textbook of cardiovascular medicine","author":"Bonow","year":"2011","edition":"9th edn"},{"key":"2024020821224747000_bib2","first-page":"199","article-title":"Right-sided infective endocarditis: recent epidemiologic changes","volume":"7","author":"Yuan","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"2024020821224747000_bib3","volume-title":"Infective endocarditis","author":"Brusch","year":"1996"},{"key":"2024020821224747000_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/340827","article-title":"Prospective study of infective endocarditis among injection drug users","volume":"185","author":"Wilson","year":"2002","journal-title":"J Infect Dis"},{"key":"2024020821224747000_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0002-9343(79)90447-9","article-title":"Recurrent infective endocarditis: analysis of predisposing factors and clinical features","volume":"66","author":"Welton","year":"1979","journal-title":"Am J Med"},{"key":"2024020821224747000_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"2024020821224747000_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/317550","article-title":"Fungal endocarditis: evidence in the world literature, 1965\u20131995","volume":"32","author":"Ellis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2024020821224747000_bib8","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s10096-012-1675-x","article-title":"Infective endocarditis in intravenous drug abusers: an update","volume":"31","author":"Sousa","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024020821224747000_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11908-003-0007-9","article-title":"Infective endocarditis in intravenous drug abusers","volume":"5","author":"Mir\u00f3","year":"2003","journal-title":"Curr Infect Dis Rep"},{"key":"2024020821224747000_bib10","first-page":"345","volume-title":"Infective endocarditis","author":"Sande","year":"1992"},{"key":"2024020821224747000_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/313664","article-title":"Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis","volume":"30","author":"Frontera","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2024020821224747000_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/infdis\/129.6.725","article-title":"Increased rate of carriage of Staphylococcus aureus among narcotic addicts","volume":"129","author":"Tuazon","year":"1974","journal-title":"J Infect Dis"},{"key":"2024020821224747000_bib13","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"N Engl J Med"},{"key":"2024020821224747000_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-82-6-788","article-title":"Staphylococcal endocarditis in parenteral drug abusers: source of the organism","volume":"82","author":"Carmeltia","year":"1975","journal-title":"Ann Intern Med"},{"key":"2024020821224747000_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-6-137","article-title":"Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients","volume":"6","author":"Ruotsalainen","year":"2006","journal-title":"BMC Infect Dis"},{"key":"2024020821224747000_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmj.1.5270.39","article-title":"Pyrexia of unknown origin","volume":"1","author":"Clegg","year":"1962","journal-title":"BMJ"},{"key":"2024020821224747000_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2024020821224747000_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/pgmj.2010.107946","article-title":"Infective endocarditis: diagnosis delayed during swine flu pandemic","volume":"87","author":"Moody","year":"2011","journal-title":"Postgrad Med J"},{"key":"2024020821224747000_bib19","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024020821224747000_bib20","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"2024020821224747000_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-4453(03)00003-3","article-title":"The microbial diagnosis of infective endocarditis","volume":"47","author":"Watkin","year":"2003","journal-title":"J Infect"},{"key":"2024020821224747000_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-152-8-201004200-00006","article-title":"Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study","volume":"152","author":"Duval","year":"2010","journal-title":"Ann Intern Med"},{"key":"2024020821224747000_bib23","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1161\/01.CIR.98.25.2936","article-title":"Diagnosis and management of infective endocarditis and its complications","volume":"98","author":"Arnold","year":"1998","journal-title":"Circulation"},{"key":"2024020821224747000_bib24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1378\/chest.107.4.898","article-title":"Endocarditis-associated paravalvular abscesses: do clinical parameters predict the presence of abscess?","volume":"107","author":"Blumberg","year":"1995","journal-title":"Chest"},{"key":"2024020821224747000_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(01)00008-3","article-title":"Infective endocarditis in intravenous drug abusers and HIV-1 infected patients","volume":"16","author":"Miro","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"2024020821224747000_bib26","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/archinte.1995.00430150125013","article-title":"Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users","volume":"155","author":"Matthew","year":"1995","journal-title":"Arch Intern Med"},{"key":"2024020821224747000_bib27","volume-title":"UpToDate","author":"Sexton"},{"key":"2024020821224747000_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-117-7-560","article-title":"Right-sided endocarditis in intravenous drug users: prognostic features in 102 episodes","volume":"117","author":"Hecht","year":"1992","journal-title":"Ann Intern Med"},{"key":"2024020821224747000_bib29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ahj.2005.02.009","article-title":"Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size","volume":"150","author":"Mart\u00edn-D\u00e1vila","year":"2005","journal-title":"Am Heart J"},{"key":"2024020821224747000_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.athoracsur.2011.08.016","article-title":"Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users","volume":"93","author":"Rabkin","year":"2012","journal-title":"Ann Thorac Surg"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/92\/1084\/105\/52543519\/postgradmedj-92-105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/92\/1084\/105\/52543519\/postgradmedj-92-105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T21:52:51Z","timestamp":1707429171000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/92\/1084\/105\/6984339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":30,"journal-issue":{"issue":"1084","published-online":{"date-parts":[[2015,12,30]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2015-133648","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,2]]},"published":{"date-parts":[[2015,12,30]]}}}